ATE237318T1 - Thixotrope formulierungen zur befüllung von gelatinekapseln - Google Patents

Thixotrope formulierungen zur befüllung von gelatinekapseln

Info

Publication number
ATE237318T1
ATE237318T1 AT99929399T AT99929399T ATE237318T1 AT E237318 T1 ATE237318 T1 AT E237318T1 AT 99929399 T AT99929399 T AT 99929399T AT 99929399 T AT99929399 T AT 99929399T AT E237318 T1 ATE237318 T1 AT E237318T1
Authority
AT
Austria
Prior art keywords
filling
compositions
consistency
gelatin capsules
pasty
Prior art date
Application number
AT99929399T
Other languages
English (en)
Inventor
Pascal Lombardin
Jean-Louis Grossiord
Monique Seiller
Elie Leverd
Eric Goutay
Jo L Bougaret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE237318T1 publication Critical patent/ATE237318T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99929399T 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln ATE237318T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808664A FR2781373B1 (fr) 1998-07-07 1998-07-07 Formulations thixotropes pour le remplissage de gelules
PCT/FR1999/001614 WO2000001371A1 (fr) 1998-07-07 1999-07-05 Formulations thixotropes pour le remplissage de gelules

Publications (1)

Publication Number Publication Date
ATE237318T1 true ATE237318T1 (de) 2003-05-15

Family

ID=9528339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929399T ATE237318T1 (de) 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln

Country Status (15)

Country Link
US (1) US6709675B1 (de)
EP (1) EP1094791B1 (de)
JP (1) JP2002519370A (de)
CN (1) CN1211124C (de)
AT (1) ATE237318T1 (de)
AU (1) AU760665B2 (de)
BR (1) BR9911905A (de)
CA (1) CA2337273A1 (de)
DE (1) DE69906974T2 (de)
DK (1) DK1094791T3 (de)
ES (1) ES2197647T3 (de)
FR (1) FR2781373B1 (de)
PT (1) PT1094791E (de)
WO (1) WO2000001371A1 (de)
ZA (1) ZA200100052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022254A1 (en) * 2001-09-10 2003-03-20 F. Hoffmann-La Roche Ag Oily thixotropic formulations
US7459146B2 (en) 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US20060153909A1 (en) * 2003-06-27 2006-07-13 Soko Motoune Hard capsule
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
CA2611724C (en) 2005-06-10 2014-07-29 Pierre Fabre Medicament S.A. Stabilized milnacipran formulation
CN100335135C (zh) * 2005-11-04 2007-09-05 天津太平洋制药有限公司 银杏叶提取物胶囊组合物及其制备方法
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
US9157063B2 (en) * 2007-01-16 2015-10-13 Texas Tech University System Method and apparatus for gender selection based on pH
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
AU2011260615B2 (en) * 2010-06-02 2016-11-17 Pharma& Schweiz Gmbh Oral dosage forms of bendamustine
US8978783B2 (en) 2011-05-26 2015-03-17 Smith International, Inc. Jet arrangement on an expandable downhole tool
JP6483031B2 (ja) * 2014-01-31 2019-03-13 富士カプセル株式会社 カプセル製剤
DE102016109669A1 (de) 2016-05-25 2017-11-30 Tiernahrung Deuerer Gmbh Verfahren zum Herstellen eines Tiernahrungsproduktes
CA3076820A1 (en) 2017-10-19 2019-04-25 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, lysopg and lysopc against drugs that cause channelopathies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
ATE99939T1 (de) * 1990-06-14 1994-01-15 Henning Berlin Gmbh Fluessig befuellte steckkapselpraeparate.
EP0517412A1 (de) * 1991-06-03 1992-12-09 MERCK SHARP & DOHME LTD. Pharmazeutische Zusammensetzungen enthaltend eine Benzodiazepen
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
DE69618956T2 (de) * 1995-06-09 2002-08-22 R.P. Scherer Technologies, Inc. Weichgelatinekapsel mit teilchenmaterial
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6365181B1 (en) * 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition

Also Published As

Publication number Publication date
DK1094791T3 (da) 2003-08-11
ES2197647T3 (es) 2004-01-01
CA2337273A1 (fr) 2000-01-13
CN1211124C (zh) 2005-07-20
FR2781373A1 (fr) 2000-01-28
WO2000001371A1 (fr) 2000-01-13
FR2781373B1 (fr) 2001-09-21
EP1094791B1 (de) 2003-04-16
AU4622799A (en) 2000-01-24
BR9911905A (pt) 2001-03-27
US6709675B1 (en) 2004-03-23
JP2002519370A (ja) 2002-07-02
DE69906974D1 (de) 2003-05-22
AU760665B2 (en) 2003-05-22
PT1094791E (pt) 2003-08-29
ZA200100052B (en) 2001-07-16
EP1094791A1 (de) 2001-05-02
CN1308522A (zh) 2001-08-15
DE69906974T2 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE237318T1 (de) Thixotrope formulierungen zur befüllung von gelatinekapseln
ATE429210T1 (de) Orale flüssige zusammensetzungen
ATE235235T1 (de) Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
RS50025B (sr) Farmaceutski preparati koji mogu da budu gelirani
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
GT200800037A (es) Solucion de cloruro de sodio para reconstitucion o dilucion de farmacos
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
ES2173708T3 (es) Composicion filmogena que comprende un poliuretano en dispersion acuosa y un agente plastificante.
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
GT199900069A (es) Preparaciones farmaceuticas estabilizadas de gabapentina y proceso para prepararla.
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
PL1952142T3 (pl) Kompozycja do rozpuszczania do badania rozpuszczalności leku
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
DE69829963D1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
DK30581A (da) Fremgangsmaade til fremstilling af 5-aminotetrazolderivater af retinsyrer
ATE329578T1 (de) Pharmazeutische zusammensetzung enthaltend xanthangummi
MX2018014407A (es) Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando.
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
Rahmawati et al. Optimization of carbopol 940 and oleic acid in diclofenac sodium base gel using factorial design 22 method

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1094791

Country of ref document: EP

REN Ceased due to non-payment of the annual fee